May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Proteome Changes Induced By Laser In Experimental Diabetic Retinopathy
Author Affiliations & Notes
  • M.C. Gillies
    Ophthalmology, University of Sydney, Sydney, Australia
  • A. Len
    Ophthalmology, University of Sydney, Sydney, Australia
  • G.J. Quin
    Ophthalmology, University of Sydney, Sydney, Australia
  • Footnotes
    Commercial Relationships  M.C. Gillies, None; A. Len, None; G.J. Quin, None.
  • Footnotes
    Support  NHMRC, Ophthalmic Research Institute of Australia
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4870. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.C. Gillies, A. Len, G.J. Quin; Proteome Changes Induced By Laser In Experimental Diabetic Retinopathy . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4870.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : The mechanism of action of limited grid laser in reducing diabetic macular oedema is poorly understood. We propose that the effect is due to the induction by laser treatment of a diffusible factor that stabilises the blood–retinal barrier. We have employed 2–dimensional gel electrophoresis and mass spectroscopic techniques to examine the proteome changes two months after laser in experimental diabetic retinopathy.

Methods: : Dark agouti rats received either sham or limited grid argon laser to one eye four weeks after hyperglycaemia was induced with streptozotocin. Eight weeks later the neuroretinae of the two groups were excised and solubilized for isoelectric focusing on 17cm pH 4.0 – 7.0 immobilized pH gradient strips. Proteins separated for the second dimension by 19 cm 8 – 18 % SDS – PAGE were Sypro Ruby stained for image analysis. Protein spots of interest were then excised for MALDI–TOF–TOF analysis.

Results: : Differential image analysis of triplicate gels revealed 9 protein spots with increased expression in lasered gels. Identifications included isovaleryl con–enzyme A dehydrogenase and alpha A crystallin. There were 24 spots with decreased expression on lasered gels including Wnt– 5b, LEK– 1, and SPIN– 2. Four uniquely expressed proteins in lasered gels included rRNA promoter binding protein. Of 13 proteins absent from lasered gels and uniquely expressed on non–lasered gels, Claudin– 12 and ATP–synthase beta unit were identified.

Conclusions: : Using proteomic techniques we have identified previously unknown protein changes attributable to limited laser treatment in diabetic retinopathy. This knowledge aids development of therapies for disorders of the blood–retinal–barrier.

Keywords: proteomics • laser • retina 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.